Abstract
Despite well-documented improvement in attention deficit hyperactivity disorder (ADHD) in youths with the available single and combined pharmacologic agents, a number of youths remain with residual symptomatology causing impairment in multiple domains. Recent work has suggested a potential cognitive-enhancing role of cholinergic agents in ADHD. We describe five cases of ADHD youths aged 8-17 years being treated for ADHD with the acetylcholinesterase inhibitor donepezil (Aricept®), all of whom demonstrated improvement.
Original language | English (US) |
---|---|
Pages (from-to) | 217-222 |
Number of pages | 6 |
Journal | Journal of child and adolescent psychopharmacology |
Volume | 10 |
Issue number | 3 |
DOIs | |
State | Published - 2000 |